Experimental gene therapies to treat hemophilia are still undergoing testing, but early results from clinical trials have both researchers and patients optimistic the condition can be cured once and for all.

Maintaining an optimal body mass index (BMI), in addition to controlling other cardiovascular risk factors, may reduce the risk of peripheral artery disease (PAD) with critical limb ischemia (CLI), according to new research in the Journal of the American Heart Association.

The factor Xa inhibitor edoxaban might reduce the risk of several adverse events—including stroke, major bleeding and all-cause death—when compared to warfarin, according to a real-world study of Korean patients with atrial fibrillation (AFib).

The FDA has approved migalastat, the first oral medication for the treatment of adults with Fabry disease, the agency announced Aug. 10.

A 45-year-old man who had a stroke now creates “eye-catching” pictures—a talent he didn’t have before the medical emergency. Wayne Sheppard of the United Kingdom now sells some of his paintings for up to $510 (or £400).

The Music Therapy Program at the Texas Health Presbyterian Hospital in Dallas integrates music into stroke patients’ healing process to help patients relax after stroke. It is also a way to help meet health targets set by patients’ speech therapists.

Swedish researchers have identified a potential mechanism for the endothelial dysfunction found in patients with type 2 diabetes (T2D): increased expression of the arginase I protein in red blood cells.

Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.